Association Between Circulating Osteoprogenitor Cell Numbers and Bone Mineral Density in Postmenopausal Osteoporosis

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2009 Jun 2

PMID 19484167

Citations 19

Authors

M Pirro

C Leli

G Fabbriciani

M R Manfredelli

L Callarelli

F Bagaglia

A M Scarponi

E Mannarino

Affiliations

Soon will be listed here.

Abstract

Unlabelled: The role of circulating osteoprogenitor cells in postmenopausal osteoporosis is unknown. We found that alkaline-phosphatase-positive (AP+) cells are the lacking cells in osteoporosis, whose reduction is related to bone loss. Conversely, the increased number of alkaline phosphatase/CD34-positive cells may reflect the reactive bone marrow contribution to bone formation.

Introduction: Circulating osteoprogenitor cells mineralize in vitro and in vivo. Loss of osteogenic cells may account for bone loss in osteoporosis. We studied whether there is an association between the number of circulating osteoprogenitor cells and bone mineral density (BMD) in postmenopausal women with and without osteoporosis.

Methods: The number of circulating AP+, osteocalcin-positive (OCN+), AP+/CD34+, and OCN+/CD34+ cells was quantified in 54 postmenopausal osteoporotic women and 36 age-matched nonosteoporotic controls.

Results: The number of AP+ cells was lower in osteoporotic women than in controls (127 +/- 16 vs 234 +/- 23 per microliter; p < 0.001); higher levels of AP+/CD34+, OCN+, and OCN+/CD34+ cells were found in osteoporotic than controls (p < 0.01 for all). The number of AP+ cells was correlated with lumbar BMD (rho = 0.29; p = 0.008) and proximal femur BMD (rho = 0.31; p = 0.005) whereas inverse correlations were found between AP+/CD34+ cells, OCN+, OCN+/CD34+, and BMD. Reduced AP+ cells and increased AP+/CD34 +, OCN+, and OCN+/CD34+ cells were predictors of low BMD, independent of traditional risk factors for osteoporosis.

Conclusion: In postmenopausal osteoporotic women, a reduced number of circulating AP+ cells and increased levels of AP+/CD34+, OCN+, and OCN+/CD34+ cells are associated with reduced bone mineral density, the interpretation of such a cellular imbalance needing exploration.

Citing Articles

Primary Osteoporosis Induced by Androgen and Estrogen Deficiency: The Molecular and Cellular Perspective on Pathophysiological Mechanisms and Treatments.

Hsu S, Chen L, Chen K Int J Mol Sci. 2024; 25(22).

PMID: 39596206 PMC: 11593909. DOI: 10.3390/ijms252212139.

Circulating Osteoprogenitor Cells Have a Mixed Immune and Mesenchymal Progenitor Function in Humans.

Feehan J, Jacques M, Kondrikov D, Eynon N, Wijeratne T, Apostolopoulos V Stem Cells. 2023; 41(11):1060-1075.

PMID: 37609930 PMC: 10631805. DOI: 10.1093/stmcls/sxad064.

Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment.

Giner M, Vazquez-Gamez M, Miranda M, Bocio-Nunez J, Olmo-Montes F, Rico M J Clin Med. 2022; 11(16).

PMID: 36012987 PMC: 9409740. DOI: 10.3390/jcm11164749.

Osteosarcopenia: A Narrative Review on Clinical Studies.

Polito A, Barnaba L, Ciarapica D, Azzini E Int J Mol Sci. 2022; 23(10).

PMID: 35628399 PMC: 9147376. DOI: 10.3390/ijms23105591.

Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome.

Chiarito M, Piacente L, Chaoul N, Pontrelli P, DAmato G, Grandone A J Endocrinol Invest. 2022; 45(6):1255-1263.

PMID: 35237949 PMC: 9098532. DOI: 10.1007/s40618-022-01760-3.

References

Johnell O, Kanis J . An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17(12):1726-33. DOI: 10.1007/s00198-006-0172-4. View

Shirley D, Marsh D, Jordan G, McQuaid S, Li G . Systemic recruitment of osteoblastic cells in fracture healing. J Orthop Res. 2005; 23(5):1013-21. DOI: 10.1016/j.orthres.2005.01.013. View

Dominici M, Pritchard C, Garlits J, Hofmann T, Persons D, Horwitz E . Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci U S A. 2004; 101(32):11761-6. PMC: 511049. DOI: 10.1073/pnas.0404626101. View

Olmsted-Davis E, Gugala Z, Camargo F, Gannon F, Jackson K, Kienstra K . Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A. 2003; 100(26):15877-82. PMC: 307661. DOI: 10.1073/pnas.2632959100. View

Ganry O, Baudoin C, Fardellone P . Effect of alcohol intake on bone mineral density in elderly women: The EPIDOS Study. Epidémiologie de l'Ostéoporose. Am J Epidemiol. 2000; 151(8):773-80. DOI: 10.1093/oxfordjournals.aje.a010277. View

Eghbali-Fatourechi G, Modder U, Charatcharoenwitthaya N, Sanyal A, Undale A, Clowes J . Characterization of circulating osteoblast lineage cells in humans. Bone. 2007; 40(5):1370-7. PMC: 1920541. DOI: 10.1016/j.bone.2006.12.064. View

Brown J, Josse R . 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002; 167(10 Suppl):S1-34. PMC: 134653. View

Montomoli M, Gonnelli S, Giacchi M, Mattei R, Cuda C, Rossi S . Validation of a food frequency questionnaire for nutritional calcium intake assessment in Italian women. Eur J Clin Nutr. 2002; 56(1):21-30. DOI: 10.1038/sj.ejcn.1601278. View

Lewiecki E, Baim S, Siris E . Osteoporosis care at risk in the United States. Osteoporos Int. 2008; 19(11):1505-9. DOI: 10.1007/s00198-008-0716-x. View

10.

Xing L, Boyce B . Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem Biophys Res Commun. 2005; 328(3):709-20. DOI: 10.1016/j.bbrc.2004.11.072. View

11.

Kotobuki N, Hirose M, Machida H, Katou Y, Muraki K, Takakura Y . Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng. 2005; 11(5-6):663-73. DOI: 10.1089/ten.2005.11.663. View

12.

Vestergaard P, Rejnmark L, Mosekilde L . Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int. 2004; 16(2):134-41. DOI: 10.1007/s00198-004-1680-8. View

13.

Hertogh E, Monninkhof E, Schouten E, Hm Peeters P, Schuit A . Validity of the modified Baecke questionnaire: comparison with energy expenditure according to the doubly labeled water method. Int J Behav Nutr Phys Act. 2008; 5:30. PMC: 2426713. DOI: 10.1186/1479-5868-5-30. View

14.

Long M, Robinson J, Ashcraft E, Mann K . Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest. 1995; 95(2):881-7. PMC: 295576. DOI: 10.1172/JCI117738. View

15.

Kumagai K, Vasanji A, Drazba J, Butler R, Muschler G . Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res. 2007; 26(2):165-75. DOI: 10.1002/jor.20477. View

16.

Voorrips L, Ravelli A, Dongelmans P, Deurenberg P, van Staveren W . A physical activity questionnaire for the elderly. Med Sci Sports Exerc. 1991; 23(8):974-9. View

17.

Kanis J, Burlet N, Cooper C, Delmas P, Reginster J, Borgstrom F . European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008; 19(4):399-428. PMC: 2613968. DOI: 10.1007/s00198-008-0560-z. View

18.

Pignolo R, Suda R, McMillan E, Shen J, Lee S, Choi Y . Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell. 2007; 7(1):23-31. PMC: 2394673. DOI: 10.1111/j.1474-9726.2007.00350.x. View

19.

Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K, Sonoyama W . Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS One. 2008; 3(7):e2615. PMC: 2440798. DOI: 10.1371/journal.pone.0002615. View

20.

Park B, Hah Y, Kim D, Kim J, Byun J . Osteogenic phenotypes and mineralization of cultured human periosteal-derived cells. Arch Oral Biol. 2007; 52(10):983-9. DOI: 10.1016/j.archoralbio.2007.04.007. View